BPI Antikörper (Biotin)
Kurzübersicht für BPI Antikörper (Biotin) (ABIN1405279)
Target
Alle BPI Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Kreuzreaktivität
- Human
- 
                                            Aufreinigung
- Purified by Protein A.
- 
                                            Immunogen
- KLH conjugated synthetic peptide derived from human CAP57
- 
                                            Isotyp
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- 
                        WB 1:300-5000
 IHC-P 1:200-400
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Konzentration
- 1 μg/μL
- 
                                            Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- 
                                            Konservierungsmittel
- ProClin
- 
                                            Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 
                                            Lagerung
- -20 °C
- 
                                            Informationen zur Lagerung
- Store at -20°C for 12 months.
- 
                                            Haltbarkeit
- 12 months
 
- 
                                            
- 
    - BPI (Bactericidal/Permeability Increasing Protein (BPI))
- 
                                            Andere Bezeichnung
- CAP57
- 
                                            Hintergrund
- 
                        Synonyms: Neutrophil Bactericidal Protein BP30, Bactericidal permeability-increasing protein, Bactericidal/permeability increasing protein, BPI, BPI_HUMAN, CAP 57, CAP-57, CAP57. Background: The cytotoxic action of BPI is limited to many species of Gram-negative bacteria, this specificity may be explained by a strong affinity of the very basic N-terminal half for the negatively charged lipopolysaccharides that are unique to the Gram-negative bacterial outer envelope. Has antibacterial activity against the Gram-nagative bacterium P.aeruginosa, this activity is inhibited by LPS from P.aeruginosa. 
- 
                                            Gen-ID
- 671
 Target
- 
                    
 
                                     
                                     
                                    